Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022
15 Septembre 2022 - 03:00PM
Philips highlights FetView cloud-based image sharing and reporting
software for obstetrics and gynecology at ISUOG 2022
September 15, 2022
Philips FetView will offer real-time, off cart remote patient
management with access to data from any ultrasound system, anytime
and anywhere, to enhance diagnostic confidence for physicians and
provide peace of mind for expectant mothers
Amsterdam, the Netherlands and London, United Kingdom
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, today announced the upcoming addition of
the FetView cloud-based fetal ultrasound image sharing and
reporting software for obstetrics/gynecology (OB/GYN). As a
vendor-neutral cloud-based platform for ultrasound images, FetView
will utilize the ultrasound image data to convey fetal growth
projections and provide a user-friendly platform for physician to
physician and physician to patient communication.
Philips Fetview is an integrated solution that combines fetal
ultrasound imaging with enhanced reporting and easy access to an
expectant mother’s medical data and fetal images. All results are
securely stored and displayed in real time. With this upcoming
addition of FetView into Philips’ advanced portfolio for Ultrasound
in OB/GYN – which includes Lumify Handheld Ultrasound, diagnostic
ultrasound systems EPIQ, Affiniti and mobile app Pregnancy+ –
pregnant women and their care teams will have access to a
comprehensive overview of how a pregnancy is progressing to help
provide peace of mind to patients and enhance diagnostic confidence
for clinicians.
With OB/GYN ultrasounds performed in different clinical
settings, immediate remote access to ultrasound images and medical
histories for collaborative decision-making and easy sharing of
images with patients is a challenge. Philips FetView will allow
physicians to view, analyze, and annotate ultrasound images in real
time via a cloud-based browser-accessible platform for secure image
sharing, to help improve quality access to care, reduce patient
mobility in case of high-risk pregnancies or post-surgery
conditions, and reduce the need to rescan patients. By enabling
full digitalization of OB/GYN workflows and patient management,
Philips FetView will help drive greater departmental efficiency,
reduce costs, and provide a better patient and staff
experience.
“I see multiple patients from many areas in my daily practice,
and the implementation of FetView has meant a turbo boost in
productivity for my practice,” said Prof. Alexander Scharf,
Managing Director, MVZ PraenatGyn, Mainz, Germany. “The
flexibility of the software is seamlessly integrated into my
existing workflows and everything I need to access in the reporting
is just one click away. FetView has also had a very positive
impact on my patients, who have showed great enthusiasm for this
program. The digital sharing of ultrasound images taken as part of
prenatal care in accordance with data protection regulations and
shared via a secure portal, help provide added peace of mind which
is so important to expectant mothers.”
“The cloud-based reporting and image sharing capabilities of
Philips FetView enhance remote communication between physicians and
patients,” said Matthijs Groot Wassink, General Manger, OB/GYN
Ultrasound at Philips. “By digitizing the workflow, we are taking
ultrasound to the next level, delivering smart ultrasound
documentation to any OB/GYN practice. The digital reporting and
image sharing, and fully customizable design are hugely helpful for
physicians, helping to drive efficiency and cost savings with
increasing patient satisfaction in their daily practice.”
Philips FetView’s vendor-neutral software will retrieve images
and measurement data via a secure encrypted DICOM interface and
display them in a structured layout where care team members can
easily add new information and data in line with their individual
specialisms and produce easy-to-read growth curves. The application
also streamlines the generation of reports in PDF format to be
uploaded to electronic patient records and shared online with other
clinicians and individual patients.
Philips FetView will be featured with additional Philips OB/GYN
solutions helping to drive earlier and more definitive diagnoses
being showcased at this year’s International Society of Ultrasound
in Obstetrics and Gynecology (ISUOG) World Congress (September 16 –
18, 2022, London, U.K.). Philips is also hosting a Satellite
Symposium [1] on September 16 at ISUOG 2022 (Hall 3, 12:30 – 13:30
BST), where international thought leaders, including Prof. Scharf,
will discuss the future of obstetric and gynecological care and
fetal medicine.
[1] Available for 12 months after the event on the ISUOG
on-demand portal
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2021 sales of EUR 17.2 billion and
employs approximately 79,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Clinician uses ultrasound in pregnancy assessment
- Clinician uses Philips ultrasound
- Philips out-of-hospital fetal ultrasound
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024